Research & Development

  • APIs: Mupirocin, Lovastatin, Mupirocin-Ca, Bacitracin, Polymyxin B.
  • Nutraceutical Ingredients: Functional fungi such as Ganoderma, Monascus, Antrodia, Cordyceps and probiotics including Bacillus coagulans, and a wide range of Latocbacillus and Bifidobacterium.

Syngen specializes in microbial fermentation, making only the best functional ingredients including probiotics, Ganoderma and Monascus. Since 1999, we have integrated advanced biotechnology with technical expertise to deliver better experiences and healthy lifestyles to all. Our research and development team is working in continuous improvements of processes, starting from upstream functional screening techniques, bacterial sample storage, pilot production and industrialization to downstream recoveries, purification, press and dehydration technologies.

Research Technologies

Culture
collection
center
Strain
identification
Fermentation
technology
Functional
screening
Explosion
proof solvent
extraction

Patents

Nutraceutical ingredients


API innovations


Quality

The quality control management system helps Syngen to assure product quality,  whether it is during research, production or storage. Syngen operates on a proven quality control management system that includes:

  • Standard operating procedures to ensure validated manufacturing processes and calibrated equipment.
  • Established analytical methods and tests that ensure each product is reproducible of quality.
  • Continous Improvement (CI) is employed so that processes and procedures are regularly updated.

Our state-of-the-art production sites are inspected by national authority (Bureau Veritas) to ensure compliance with ISO 9001 and 22000 requirements. All products are manufactured in compliance with the requirements of current Good Manufacturing Practice (cGMP), and certified by Taiwan Food and Drug Administration (TFDA).

Awards

2018

Golden Award for Pharmaceutical Technology Research and Development-Mupirocin

2018

Oral probiotics SG-A95 and SG-M6 awarded Gold at ITEX Exhibition, Malaysia

2018

API Mupirocin awarded Go-Global Award in 2018 Taipei Biotech Awards

2017

Cordyceps sinensis awarded the Cultivation Technology Innovation Prize

2017

API Mupirocin Ca awarded Gold the API Research Development Prize

2016

Recognised as a leading technology company in the Technology Fast 500 Asia Pacific 2016 Program by Deloitte

2014

Syngen API Mupirocin awarded bronze at the National Biotechnology Medical Quality Awards

2014

Syngen API Mupirocin awarded The Symbol of National Quality

2011

Bronze award for Taiwan Healthcare and Agricultural Biotech Ingredients Innovation and Excellence

2010

TOP 500 Company in Management Achievement

2008

Recognised as the top-rated company in the Small Business Innovation Research Program by the Ministry of Economic Affairs

2005

Silver Prize for National Pharmaceutical Technology Research of API Bacitracin Zinc

2004

Bronze award for Pharmaceutical Technology Research & Development from Taiwan Department of Health

2004

API Bacitracin Zinc awarded Silver for National Pharmaceutical Technology Research

2004

Awarded the 3rd Pharmaceutical Technology Research & Development Prize

2003

Awarded the Organizational Learning Prize by the Taiwan government

2003

Recognised as Newly Important Strategic Industry by the Taiwan government

2003

Gold prize for National Innovation of Nutritional Ingredient Monascus

SYNGEN BIOTECH
An affiliate of Standard Group
4F., No.158, Songjiang Rd., Zhongshan Dist.,
Taipei City 104, Taiwan.
+886-2-2523-6641 ext8261
Fax:
+886-2-2521-5727
Get in touch RIGHT NOW